|Bid||275.51 x 800|
|Ask||276.40 x 1800|
|Day's Range||275.00 - 296.90|
|52 Week Range||67.10 - 464.00|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 09, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||332.87|
Dr. David Katz, Preventive Medicine Specialist & True Health Initiative President joins Yahoo Finance to discuss the state of the COVID-19 pandemic as fall begins.
Pfizer has submitted data to health regulators on the pivotal trial of its Covid-19 vaccine in young children, but hasn't formally asked for an emergency-use authorization yet.
BioNTech is the IBD Stock Of The Day. After running up aggressively in August, BNTX is now embroiled in a storm of sell signals.